HB 987 – Mississippi
Introduced: 2023 Status: Inactive / Dead
An act to amend section 73-21-153, mississippi code of 1972, to define new terms and revise the definitions of existing terms under the pharmacy benefit prompt pay act; to create new section 73-21-154, mississippi code …
HF 423 – Iowa
Introduced: 2024 Status: In Process
This bill pertains to the contractual relationship between pharmacies and covered entities participating in the 340B drug program. The 340B drug program, established under the Veterans Health Care Act of 1992, allows eligible healthcare providers, …
HF 423 (see companion bill SF 419) – Iowa
Introduced: 2023 Status: Enacted
This Act relates to contract pharmacies and covered entities that participate in the 340B program. The Act defines “340B program,” “contract pharmacy,” and “covered entity.”
HSB 590 – Iowa
Introduced: 2024 Status: In Process
This bill relates to manufacturers and wholesalers of 340B drugs. “340B drug”, “manufacturer”, and “wholesaler” are defined in the bill. The bill prohibits a manufacturer or wholesaler from, directly or indirectly, denying, restricting, or interfering …
LB 984 – Nebraska
Introduced: 2024 Status:
This bill aims to regulate the actions relating to the distribution of drugs by 340B entities. A 340B entity refers to an entity authorized to participate in the federal 340B drug discount program which allows …
LD 1395 – Maine
Introduced: 2023 Status: Enacted
This bill requires each hospital to provide an annual report to the Maine Health Data Organization with hospital data, drug data and contracting and vendor data related to its participation in the federal 340b drug …
LD 1428 – Maine
Introduced: 2023 Status: Inactive / Dead
This bill prohibits prior authorization requirements and step therapy protocols under the MaineCare program for prescription drugs used to assess or treat serious mental illness. The implementation of the prohibition must be consistent with the …
LD 1938 – Maine
Introduced: 2021 Status: Inactive / Dead
An Act To Prohibit Discriminatory Practices Related to the 340B Drug Pricing Program
S 3962 (see companion bill A 5588) – New Jersey
Introduced: 2023 Status: In Process
Requires prescription drug services covered under Medicaid program to be provided via fee-for-service delivery system.
S 5136 (see companion bill A 5911) – New York
Introduced: 2023 Status: In Process
Relates to pharmacy services provided by managed care providers; requires pharmacy benefit managers and managed care providers to reimburse retail pharmacies for each outpatient drug, at the National Average Drug Acquisition Cost (NADAC); repeals related …
S 704 (see companion bill H 959) – Massachusetts
Introduced: 2023 Status: In Process
An Act prohibiting discrimination against 340b drug discount program participants
SB 10 – Connecticut
Introduced: 2023 Status: Inactive / Dead
An Act promoting access to affordable prescription drugs, health care coverage, transparency in health care costs, home and community-based support for vulnerable persons and rights regarding gender identity and expression.
SB 102 – California
Introduced: 2019 Status: Inactive / Dead
SB 1088 – Michigan
Introduced: 2022 Status: Inactive / Dead
Insurance: third party administrators; restrictions relating to a pharmacy benefit manager’s interaction with a 340B program entity; modify. Amends sec. 26 of 1984 PA 218 (MCL 550.926).
SB 1205 (see companion bill HB 1348) – Tennessee
Introduced: 2021 Status: Inactive / Dead
As introduced, prohibits certain health insurance issuers, managed health insurance issuers, pharmacy benefits managers, or other third-party payers from taking certain actions against entities participating in the federal 340B drug discount program. – Amends TCA …
SB 1251 – Arizona
Introduced: 2024 Status: In Process
This bill amends the Arizona Revised Statutes title 32, chapter 18, article 3 by adding a new section. The main focus of the bill is the regulation of prescription drugs under the 340B Drug Pricing …